Integer Holdings Corp (ITGR) Stock AnalysisITGRInteger Holdings Corp

Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation. It operates in the Healthcare sector (ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS industry).

Integer Holdings Corp is currently a hold. The stock is priced at $126.61, very close to the acquisition price of $127 per share, which limits upside potential. The RSI is at 73.156, indicating it is overbought. Additionally, the forward P/E ratio is 22.42, suggesting it is relatively expensive compared to its earnings growth prospects. The main risk is the slowing revenue growth projected at only 1.6% over the next year, which could impact profitability.

5 analysts cover ITGR: 2 rate it Buy, 3 Hold and 0 Sell. The average price target is 86.25.